Speaker illustration

Mr Jul Lambermont

Leuven (Belgium)

Member of:

European Society of Cardiology

Jul Lambermont is a medical student at KU Leuven and, since 2024, an affiliated researcher at the Broad Institute of MIT and Harvard with support from a Belgian American Educational Foundation fellowship. His work spans cardiovascular prevention, epidemiology, clinical cardiology and genomics, with a focus on improving prevention and advancing precision medicine—examining how population trends, lifestyle and clinical factors, and genetics shape heart-disease risk over a lifetime. He’s currently leveraging large, real-world datasets to build multidomain models that uncover patterns in postoperative cardiac events. He hopes these insights will enable earlier identification of at-risk patients and improve long-term care. In his spare time, he enjoys running, cycling, and spending time with friends.

Association of clinical, lifestyle, and genetic risk factors with outcomes after coronary artery bypass grafting

Event: ESC Congress 2025

Topic: Secondary Prevention

Session: Secondary prevention: biomarkers to optimise outcomes

Thumbnail